Hong Kong Stock Market Surges | GL Pharmaceuticals-B (01672.HK) Up Over 4% Company Announces Oral Dual-target Compound Will Further Expand the Value of ASC30 Platform.

According to the Securities Times app, G-Life Pharma-B (01672.HK) has risen by more than 4%, as of the time of publication, it has risen by 3.79%, to HK$8.76, with a turnover of HK$1045.03 million.